The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00114855|
Recruitment Status : Completed
First Posted : June 20, 2005
Last Update Posted : July 6, 2011
|Condition or disease||Intervention/treatment||Phase|
|Hyperlipidemia Glucose Metabolism Disorders||Drug: HYPOCOL®||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||A Single-Centre, Randomised Double-Blind Placebo-Controlled Study to Measure the Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose|
|Study Start Date :||March 2005|
|Actual Primary Completion Date :||December 2005|
|Actual Study Completion Date :||June 2006|
- The effect of HypoCol on lipids in subjects with mild hypercholesterolemia.
- The effect of HypoCol on fasting glucose, glycosylated hemoglobin (HbA1c) and high sensitive CRP.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00114855
|Oslo, Norway, 0027|
|Principal Investigator:||Kjetil Retterstøl, Dr. med||Oslo University Hospital|